Modulating the profit motive to meet needs of the less-developed world

This publication has 10 references indexed in Scilit:

• South Africa's moral victory
  The Lancet, 2001
• Uneasy Alliance — Clinical Investigators and the Pharmaceutical Industry
  New England Journal of Medicine, 2000
• Is orphan drug status beneficial to tropical disease control? Comparison of the American and future European orphan drug acts
  Tropical Medicine & International Health, 1999
• Access to Essential Drugs in Poor CountriesA Lost Battle?
  JAMA, 1999
• Equivalence Trials
  New England Journal of Medicine, 1997
• Trials to assess equivalence: the importance of rigorous methods
  BMJ, 1996
• The Economics of Orphan Drug Policy in the US
  PharmacoEconomics, 1995
• Trends in Drug Development Costs, Times, and Risks
  Drug Information Journal, 1995
• Research and Development Costs for New Drugs by Therapeutic Category
  PharmacoEconomics, 1995
• Orphan Products: Origins, Progress, and Prospects
  Annual Review of Pharmacology and Toxicology, 1991